Skip to main content
. 2023 Nov 3;5(6):fcad296. doi: 10.1093/braincomms/fcad296

Table 1.

Demographic data in patients with confirmed CBD pathology (CBD) and clinical diagnosis of CBS or CBD with non-CBD pathology (CBD mimics)

Feature CBD CBD mimics P-value (95% CI)
n = 32 n = 32
Age at onset, years 65.4 ± 8.1 (45–83) 66.0 ± 10.4 (33–86) 0.820 (−5.17 to 4.13)
M:F ratio 16:16 22:10 0.203, OR: 0.45 (0.45–1.26)
Time at presentation since onset of symptoms, years 3.4 ± 2.4 (0–9) 3.7 ± 3.1 (0–12) 0.667 (−1.69 to 1.09)
Age at death, years 73.0 ± 8.2 (50–87) 74.3 ± 10.0 (48–93) 0.578 (−5.84 to 3.30)
Duration of disease, years 7.8 ± 3.1 (3–17) 9.6 ± 5.5 (3–31) 0.108 (−4.02–0.41)

Data are presented as mean ± SD (range). M, male; F, female; OR, odds ratio; 95% CI, 95% confidence interval.